Quality & Productivity

Viral Safety and Viral Clearance: Model Viruses, Spiking Studies and LRV Claims – London, 4–8 Oct 2027

Viral Safety and Viral Clearance: Model Viruses, Spiking Studies and LRV Claims runs in London from Monday 4 October to Friday 8 October 2027 (1 Week). The fee is 23,000 SAR per participant. The same programme is also scheduled in 7 other cities.

Register for this programme Ask a question

Dates
Length
1 Week
Fee per participant
23,000 SAR
Format
In person, London
Venue
Central London four-star
Status
Open for registration
Week
40 of 2027
Reference
678_18702

This session

4–8 Oct 2027

This Viral Safety and Viral Clearance: Model Viruses, Spiking Studies and LRV Claims session in London runs from Monday 4 October to Friday 8 October 2027 (week 40, Q4 2027). It is the 2nd of 2 dates in London in 2027, at a fee of 23,000 SAR, the same for each of them. Registration is open for this date. It is held in person at Central London four-star.

When else does it run in London?

How do I book this date?

Register online to request your place, or send us a question about this date first.

Reference for this date: 678_18702. Quote it when you contact us.

Before you book, read our cancellation policy.

Let’s talk about your next step.

Questions about this date

When does Viral Safety and Viral Clearance: Model Viruses, Spiking Studies and LRV Claims in London start and finish?

It starts on Monday 4 October and finishes on Friday 8 October 2027: 1 Week.

How much does Viral Safety and Viral Clearance: Model Viruses, Spiking Studies and LRV Claims in London cost?

The fee for this date is 23,000 SAR per participant. Please read our cancellation policy before you book.

Is this date held in person or online?

It is held in person in London, at Central London four-star.

Where else does Viral Safety and Viral Clearance: Model Viruses, Spiking Studies and LRV Claims run?

It is also scheduled in 7 other cities: Amsterdam, Barcelona, Dammam, Dubai, Jeddah, Paris and Riyadh.

What does this programme cover?

Viral safety and viral clearance failures in biomanufacturing rarely start at the virus filter: they start with an untested raw material, a scale-down column that does not mirror the production step, or a clearance claim that adds log reductions from steps sharing one mechanism. This Core Concept course equips bioprocess, quality, validation and CMC teams to control viral risk across source materials, purification design and product testing, and to defend log reduction values in a filing. Participants produce a Viral Clearance Strategy and Study Plan for a case monoclonal antibody process.

The programme outline covers:

  • Introduction
  • Course Objectives
  • Target Audience
  • Course Outline
  • Day 1: Viral Contamination Risk and the Viral Safety Triad
  • Day 2: Cell Bank Qualification, Raw Material Controls and ICH Q5A Principles
  • Day 3: Inactivation and Removal Steps and Model Virus Selection
  • Day 4: Scale-Down Models, Spiking Study Design and Log Reduction Value Calculation
  • Day 5: Case Study: Viral Clearance Strategy for a Monoclonal Antibody Process
  • Skills You Will Gain
  • Why Attend This Course
  • Conclusion
Read the full outline on the programme page ↗

Where else does this programme run?

Also scheduled in 7 other cities.

More ways to train